Metabolomic Technologies Formed to Commercialize Test for Colon Polyps; Partners with BGI | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Alberta, the Alberta government, and BGI Shenzhen are collaborating on accelerating the commercialization of a new metabolomics-based test for detecting pre-cancerous polyps with the formation of a new company, they announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.